CEROVATIONS
Innovations in Neurocritical Care

An innovative approach to medtech licensing

Partner Option Program

 

A Structure & Process That Works for Your Medtech Innovations

Would you like a new, effective tool in your medtech licensing toolbox to enable more rapid licensing to corporate partners?

Cerovations’ Partner Option Program (POP) brings experience and entrepreneurial energy to your technology concept at reduced risk and at a faster pace than might be achieved through other licensing approaches.

 
partner-option-program-cerovations-medtech.png
 
 

THE PROBLEM

University technology managers for medical device inventions are unable to rapidly license IP to  an “interested’” corporate partner due to several potential barriers, including:

  1. The technology is at an early stage, and there is little, if any, substantiating proof of clinical efficacy

  2. Corporate partner has insufficient budget and/or staff to assess the early stage invention, and to plan the steps necessary to de-risk the opportunity

  3. University inventor and staff do not have skill set to undertake medical device development steps  

  4. Corporate partner discomfort funding University investigators who are unfamiliar with medical device development requirements (such as quality system documentation)

  5. Corporate partner unwilling to engage in licensing negotiations due to more pressing priorities and lack of experience with early stage invention licensing negotiation process and terms

Cerovations’ Partner Option Program (POP) de-risks and develops technologies with external resources and non-dilutive funding.

The Solution

Cerovations’ Partner Option Program (POP) provides university technology managers with a powerful tool for closing a license deal to further the commercialization of a medtech invention.  Key elements of POP include:

  1. Cerovations concurrently enters into two partner agreements: 

    1. Secures license agreement with university;

    2. Negotiates option agreement with corporate partner;

  2. Cerovations prepares and submits NIH SBIR/STTR Phase I grant (likely including subaward to University)

    1. NIH funds Phase I research approach

    2. Corporate partner provides project design input and letters of support 

    3. Corporate partner has option to fund Phase I research approach (in the event NIH does not fund)

  3. Cerovations prepares and submits NIH SBIR/STTR Phase II grant (likely including subaward to University)

    1. NIH funds Phase II research approach

    2. Corporate partner exercises option to license or acquire university invention and Cerovations’ invention-related intellectual property 

    3. If Corporate partner does not exercise option, they can receive a percentage of (net) transaction value for invention IP sold or licensed to another interested party

Next steps

Ready to get started and learn more?

  1. Meet us at AUTM Exhibitor Booth #221, or

  2. Organize an introductory virtual Cerovations presentation with your University technology commercialization team, or

  3. Request a call with your University inventor to discuss medtech invention status and fit with SBIR/STTR program

Contact us

If you have any questions about Cerovations, LLC or would like to get in touch with a member of our team, please contact us at info@cerovations.com.